Skip to content

Avanos Medical AVNS Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$2K
Medtronic logo
MedtronicMDT
$97M-10.2%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$394K-74.6%
Baxter International logo
Baxter InternationalBAX
$8M-20.0%
Globus Medical logo
Globus MedicalGMED
$25.96M+131%
Enovis logo
EnovisENOV
$628K+84.2%

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's stock issuance proceeds?
Avanos Medical (AVNS) reported stock issuance proceeds of $400K in Q1 2026.
How has Avanos Medical's stock issuance proceeds changed year-over-year?
Avanos Medical's stock issuance proceeds decreased by 0.0% year-over-year, from $400K to $400K.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.